ATE353137T1 - Kompositionen und verfahren zum nachweis von treponema pallidum - Google Patents
Kompositionen und verfahren zum nachweis von treponema pallidumInfo
- Publication number
- ATE353137T1 ATE353137T1 AT00941424T AT00941424T ATE353137T1 AT E353137 T1 ATE353137 T1 AT E353137T1 AT 00941424 T AT00941424 T AT 00941424T AT 00941424 T AT00941424 T AT 00941424T AT E353137 T1 ATE353137 T1 AT E353137T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- treponema pallidum
- treponema
- specific
- detection
- Prior art date
Links
- 241000589884 Treponema pallidum Species 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000006379 syphilis Diseases 0.000 abstract 2
- 241000589886 Treponema Species 0.000 abstract 1
- 206010044587 Treponema infections Diseases 0.000 abstract 1
- 208000025884 Treponema infectious disease Diseases 0.000 abstract 1
- 208000035055 Treponemal Infections Diseases 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 201000003595 bejel Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 208000009090 primary syphilis Diseases 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000011896 sensitive detection Methods 0.000 abstract 1
- 201000009482 yaws Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13898199P | 1999-06-14 | 1999-06-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE353137T1 true ATE353137T1 (de) | 2007-02-15 |
Family
ID=22484572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00941424T ATE353137T1 (de) | 1999-06-14 | 2000-06-14 | Kompositionen und verfahren zum nachweis von treponema pallidum |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7005270B2 (https=) |
| EP (1) | EP1240519B1 (https=) |
| JP (1) | JP2003510559A (https=) |
| CN (1) | CN1185255C (https=) |
| AT (1) | ATE353137T1 (https=) |
| AU (1) | AU775526B2 (https=) |
| BR (1) | BR0011624A (https=) |
| CA (1) | CA2375924A1 (https=) |
| DE (1) | DE60033241T2 (https=) |
| WO (1) | WO2000077486A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000077486A2 (en) * | 1999-06-14 | 2000-12-21 | The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Compositions and methods for detecting treponema pallidum |
| JP3883934B2 (ja) * | 2002-08-29 | 2007-02-21 | 富士フイルムホールディングス株式会社 | 生化学解析用ユニットを利用した化学発光法 |
| WO2007066731A1 (ja) * | 2005-12-07 | 2007-06-14 | Sekisui Medical Co., Ltd. | 抗リン脂質抗体測定試薬及び抗トレポネーマ・パリダム抗体測定試薬 |
| JP4629563B2 (ja) * | 2005-12-07 | 2011-02-09 | 積水メディカル株式会社 | 抗リン脂質抗体測定試薬 |
| CN101858914B (zh) * | 2010-05-19 | 2013-03-27 | 厦门大学附属中山医院 | 梅毒特异性总抗体胶体金免疫层析检测试剂条及其制备方法 |
| RU2474820C2 (ru) * | 2011-04-11 | 2013-02-10 | Виктория Олеговна Пожарская | Способ контроля эффективности лечения сифилиса |
| US8945827B2 (en) | 2013-03-13 | 2015-02-03 | Awareness Technology, Inc. | Serological methods and diagnostic tests for syphilis antibodies |
| CN111593132B (zh) * | 2020-06-09 | 2024-07-05 | 柯吴坚 | 一种基于tp0136基因异质性用于区分梅毒螺旋体不同亚型的分子分型方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4738932A (en) * | 1985-12-03 | 1988-04-19 | Advanced Polymer Systems, Inc. | Reaginic test for syphilis |
| US4894328A (en) * | 1986-03-26 | 1990-01-16 | Board Of Regents, The University Of Texas System | Immunodiagnostic test for syphilis and other treponemal infections |
| US5965702A (en) * | 1991-10-21 | 1999-10-12 | Abbott Laboratories | Borrelia burgdorferi antigens and uses thereof |
| US5330754A (en) * | 1992-06-29 | 1994-07-19 | Archana Kapoor | Membrane-associated immunogens of mycobacteria |
| GB9314011D0 (en) * | 1993-07-07 | 1993-08-18 | Porton Cambridge Ltd | New diagnostic assay for detection of syphilis |
| US5753459A (en) * | 1994-01-06 | 1998-05-19 | The Regents Of The University Of California | Nucleotide sequences of T. pallidum rare outer membrane protein |
| WO2000077486A2 (en) * | 1999-06-14 | 2000-12-21 | The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Compositions and methods for detecting treponema pallidum |
-
2000
- 2000-06-14 WO PCT/US2000/016425 patent/WO2000077486A2/en not_active Ceased
- 2000-06-14 CN CNB008089426A patent/CN1185255C/zh not_active Expired - Fee Related
- 2000-06-14 AT AT00941424T patent/ATE353137T1/de not_active IP Right Cessation
- 2000-06-14 EP EP00941424A patent/EP1240519B1/en not_active Expired - Lifetime
- 2000-06-14 JP JP2001503496A patent/JP2003510559A/ja active Pending
- 2000-06-14 CA CA002375924A patent/CA2375924A1/en not_active Abandoned
- 2000-06-14 AU AU56131/00A patent/AU775526B2/en not_active Ceased
- 2000-06-14 BR BR0011624-6A patent/BR0011624A/pt not_active IP Right Cessation
- 2000-06-14 DE DE60033241T patent/DE60033241T2/de not_active Expired - Fee Related
-
2001
- 2001-12-14 US US10/017,168 patent/US7005270B2/en not_active Expired - Fee Related
-
2005
- 2005-09-06 US US11/221,263 patent/US7335736B2/en not_active Expired - Fee Related
-
2007
- 2007-12-26 US US11/964,552 patent/US20080139783A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003510559A (ja) | 2003-03-18 |
| DE60033241T2 (de) | 2007-11-15 |
| BR0011624A (pt) | 2002-06-11 |
| US7005270B2 (en) | 2006-02-28 |
| EP1240519A2 (en) | 2002-09-18 |
| AU5613100A (en) | 2001-01-02 |
| CN1185255C (zh) | 2005-01-19 |
| US7335736B2 (en) | 2008-02-26 |
| WO2000077486A2 (en) | 2000-12-21 |
| DE60033241D1 (de) | 2007-03-22 |
| HK1050728A1 (en) | 2003-07-04 |
| CA2375924A1 (en) | 2000-12-21 |
| US20050191712A1 (en) | 2005-09-01 |
| US20060051823A1 (en) | 2006-03-09 |
| US20080139783A1 (en) | 2008-06-12 |
| EP1240519B1 (en) | 2007-01-31 |
| AU775526B2 (en) | 2004-08-05 |
| WO2000077486A3 (en) | 2002-07-11 |
| CN1399722A (zh) | 2003-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200512457A (en) | Method of diagnosing SARS corona virus infection | |
| DE60139963D1 (de) | Fusionsproteine aus mycobakterium tuberculosis | |
| EE200300128A (et) | Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt | |
| CY1109554T1 (el) | Μεθοδοι και αντιδραστηρια για την ανιχνευση ενδοτοξινης | |
| EP1636561A4 (en) | SCREENING OF COMBINATORY PROTEIN LIBRARIES BY PERIPLASMATIC EXPRESSION | |
| ATE353137T1 (de) | Kompositionen und verfahren zum nachweis von treponema pallidum | |
| ATE418072T1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| BRPI0200986B8 (pt) | método de determinação da presença de hcv em uma amostra | |
| SG135990A1 (en) | Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody | |
| WO2003012395A3 (en) | Early detection of mycobacterial disease using peptides | |
| BR0206902A (pt) | Composições e processos para detectar treponema pallidum | |
| DE60239715D1 (de) | Nachweis des bovinen Virusdiarrhoe-Virus in Gewebeproben | |
| Ashburn et al. | Improved diagnosis of reactivated toxoplasmosis | |
| Yathi et al. | Recombinant CHIK virus E1 coat protein of 11 KDa with antigenic domains for the detection of Chikungunya | |
| ATE426038T1 (de) | Nachweis des rinderdiarrhoevirus in haarproben | |
| Aguirre et al. | Results from an indirect fluorescent antibody test using three different strains of Ehrlichia canis | |
| WO2006088740A3 (en) | Methods and compositions for impairing multiplication of hiv-1 | |
| ATE540052T1 (de) | Neue peptide, die epitope des humanen herpesvirus 8 darstellen | |
| Motzel | Serologic diagnosis of Bacillus piliformis. | |
| DE69809576D1 (de) | Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm | |
| WO2005047308A3 (en) | Peptide-based diagnostic reagents for sars | |
| Marangoni et al. | Use of a surface immunofluorescence assay for serological diagnosis of syphilis | |
| FR2874017B1 (fr) | Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih | |
| TR200603810A2 (tr) | Mycoplasma Gallisepticum enfeksiyonları immünodiyagnostik reaktif ve araçları | |
| FR2839721B1 (fr) | Antigene polypeptidique induisant des anticorps neutralisant le vih |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |